Growth Metrics

DBV Technologies (DBVT) Shares Outstanding (Diluted Average) (2021 - 2026)

DBV Technologies (DBVT) reported Shares Outstanding (Diluted Average) of $428.3 million for Q1 2026, up 317.38% year-over-year from $102.6 million in Q1 2025, and up 206.86% on a QoQ basis from $139.6 million in Q4 2025.

DBV Technologies (DBVT) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $428.3 million in Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 317.38% year-over-year to $428.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428.3 million (up 317.38% YoY) and the FY2025 annual result came in at $139.6 million, up 43.9% from the prior year.
  • Shares Outstanding (Diluted Average) rose to $428.3 million in Q1 2026 per DBVT's latest filing, from $139.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $428.3 million in Q1 2026 and bottomed at $54.9 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $96.2 million (2024), against an average of $115.2 million.
  • The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) climbed 0.12%; it then surged 317.38% in 2026.
  • Tracing DBVT's Shares Outstanding (Diluted Average) over 5 years: stood at $77.4 million in 2022, then increased by 22.92% to $95.1 million in 2023, then climbed by 1.97% to $97.0 million in 2024, then surged by 43.9% to $139.6 million in 2025, then surged by 206.86% to $428.3 million in 2026.
  • Per Business Quant, the three latest DBVT Shares Outstanding (Diluted Average) figures stand at $428.3 million (Q1 2026), $139.6 million (Q4 2025), and $124.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 428.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 428.30 Mn
Dec 31, 2025 139.57 Mn
Sep 30, 2025 124.72 Mn
Jun 30, 2025 134.48 Mn
Mar 31, 2025 102.62 Mn
Dec 31, 2024 97.00 Mn
Sep 30, 2024 96.19 Mn
Jun 30, 2024 96.18 Mn
Mar 31, 2024 96.18 Mn
Dec 31, 2023 95.12 Mn
Sep 30, 2023 96.08 Mn
Jun 30, 2023 94.15 Mn
Mar 31, 2023 93.97 Mn
Dec 31, 2022 77.38 Mn
Sep 30, 2022 71.78 Mn
Jun 30, 2022 60.49 Mn
Mar 31, 2022 54.93 Mn
Dec 31, 2021 54.92 Mn
Sep 30, 2021 54.95 Mn
Jun 30, 2021 54.89 Mn